The Physiological Rationale for Incorporating Pulsatility in Continuous-Flow Left Ventricular Assist Devices
- 1 November 2018
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cardiology in Review
- Vol. 26 (6), 294-301
- https://doi.org/10.1097/crd.0000000000000202
Abstract
Over the past few decades, left ventricular assist device (LVAD) support has extended the lives of many patients with end-stage heart failure. The most common devices are continuous-flow (CF) LVADs. The use of the CF-LVADs has required that clinicians learn the physiological and clinical consequences of long-term continuous blood flow. While this alteration in the normal physiology still offers advantages from mechanical circulatory support, the lack of pulsatility may also increase the likelihood of adverse events. However, it is currently unknown whether newly evolved devices should incorporate pulsatility. In this article, we discuss the possible benefits of incorporating pulsatility, while maintaining the benefits of the CF-LVAD, to maximize the treatment of patients.Keywords
This publication has 97 references indexed in Scilit:
- Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and RemodelingCirculation: Heart Failure, 2011
- Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patientsEuropean Journal of Cardio-Thoracic Surgery, 2011
- Focused Review on Transthoracic Echocardiographic Assessment of Patients with Continuous Axial Left Ventricular Assist DevicesCardiology Research and Practice, 2011
- The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported PatientsCirculation: Heart Failure, 2010
- Effects of Centrifugal, Axial, and Pulsatile Left Ventricular Assist Device Support on End-Organ Function in Heart Failure PatientsThe Journal of Heart and Lung Transplantation, 2009
- Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortalityJournal of Hypertension, 2008
- End-organ Function in Patients on Long-term Circulatory Support With Continuous- or Pulsatile-flow Assist DevicesThe Journal of Heart and Lung Transplantation, 2007
- Peripheral Vascular Reactivity in Patients With Pulsatile vs Axial Flow Left Ventricular Assist Device SupportThe Journal of Heart and Lung Transplantation, 2006
- Brain Natriuretic Peptide is Produced Both by Cardiomyocytes and Cells Infiltrating the Heart in Patients with Severe Heart Failure Supported by a Left Ventricular Assist DeviceThe Journal of Heart and Lung Transplantation, 2006
- Insights from Continued Use of a Novacor Left Ventricular Assist System for a Period of 6 YearsThe Journal of Heart and Lung Transplantation, 2005